S100A9 and hepatocellular carcinoma: Similarly, S100A9 + MDSCs activate the ERK/NF-κB pathway in HCC cells, creating a self-sustaining “ETV5-S100A9-ERK/NF-κB” loop via ETV5 upregulation, which accelerates tumor progression[55].